COMP <GO>
MLSS vs ABBV // GROSS PROFIT MARGIN
Milestone Scientific Inc. (NYSE) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: MLSS 3
— ABBV 7
▲ GROSS PROFIT MARGIN LEADER: MLSS
LAST: $0.32 (-0.54%) • MKT CAP: $28.6M
gross-margins
71.40%
LAST: $290.79 (+1.68%) • MKT CAP: $513.86B
gross-margins
70.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MLSS VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MLSS | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 71.40% | 70.20% | +1.20 | MLSS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 29.00% | -64.00 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 33.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -10.27% | 3.47% | -13.74 | ABBV | /fcf-yield <GO> |
| Operating Margin | -60.00% | 24.60% | -84.60 | ABBV | /operating-margins <GO> |
| Net Profit Margin | 63.80% | 6.90% | +56.90 | MLSS | /net-margins <GO> |
| Revenue Growth (YoY) | — | 8.60% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.33 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | ABBV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 31.1 | 65.1 | -34.01 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.15 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 4.7x | 113.1x | -108.40 | MLSS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $28.6M | $513.86B | -$513.83B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MLSS REV | ABBV REV | MLSS GROSS % | ABBV GROSS % | MLSS FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $9.0M | $61.16B | 71.4% | 70.2% | -$2.9M | $17.82B |
| FY 2024 | $8.6M | $56.33B | 74.6% | 70.0% | -$2.9M | $17.83B |
| FY 2023 | $0 | $54.32B | — | — | -$5.3M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MLSS // BETA —
ABBV // BETA 1.15